Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Depression

Cognitive training may reduce negative self-perceptions in people with depression and PTSD

by Eric W. Dolan
May 21, 2025
in Depression, PTSD
Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

People with depression and posttraumatic stress disorder tend to underestimate their cognitive abilities—a pattern that may worsen their mental health. A new study published in Neuropsychology provides evidence that this negative self-perception, known as metacognitive bias, is both common and severe in individuals with high levels of depressive and PTSD symptoms. The researchers also found that targeted or game-based cognitive training can improve these biases and may contribute to a reduction in symptom severity.

Depression and PTSD are two of the most common mental health conditions, often marked by persistent negative thoughts and emotional distress. Depression is characterized by symptoms such as sadness, low energy, and loss of interest in daily activities, while PTSD can involve intrusive memories, avoidance of reminders, emotional numbness, and heightened arousal following exposure to traumatic events. Both conditions are known to distort how individuals perceive themselves and the world around them.

In recent years, researchers have become increasingly interested in how metacognition—the ability to reflect on and evaluate one’s own thoughts and abilities—may influence mental health. One important aspect of metacognition is “metacognitive bias,” or the tendency to systematically overestimate or underestimate one’s own abilities.

While people in the general population often show a slight tendency to overestimate themselves, this study focused on the opposite problem: large-scale underestimation among individuals with depression and PTSD. The researchers wanted to examine how strongly these negative self-perceptions were related to symptoms and whether cognitive training could help reduce them.

To explore these questions, researchers reanalyzed data from a randomized controlled trial known as the BRAVE study, which involved 84 participants, mostly military veterans, who had experienced mild traumatic brain injuries and reported cognitive difficulties. About three-quarters of the participants had either elevated depression, PTSD symptoms, or both.

The participants were randomly assigned to one of two 13-week training programs: a “targeted cognitive training” group that completed computerized exercises designed to improve attention, memory, and executive function, or an “entertainment training” group that played puzzle and board games like Tetris and Solitaire.

Before and after the training, participants completed a variety of assessments. Self-reported cognitive performance was measured using the Cognitive Failures Questionnaire, a validated 25-item scale that captures daily lapses in attention and memory. Objective cognitive performance was evaluated using a battery of tests measuring learning, memory, working memory, attention, and cognitive flexibility. By comparing self-perceived and actual performance, researchers calculated each participant’s metacognitive bias. Depression and PTSD symptoms were also measured using well-established clinical questionnaires.

At the start of the study, the researchers found that people with elevated depression or PTSD symptoms significantly underestimated their cognitive abilities compared to their actual test scores. On average, participants with both conditions scored nearly 2.3 standard deviations below the norm in their self-assessments, despite relatively mild objective impairments. This discrepancy—referred to as a negative global metacognitive bias—was strongly linked to the severity of depression and PTSD symptoms. The researchers found no evidence that these negative biases were linked to specific types of cognitive impairment, suggesting that they reflect a broader pattern of self-doubt rather than performance in a particular area.

Over the 13-week intervention period, participants in both the targeted and entertainment training groups showed notable improvements. Those who completed either program reported fewer cognitive problems, reduced depression symptoms, and improved metacognitive accuracy. Importantly, the size of the improvement in metacognitive bias was correlated with the reduction in both depression and PTSD symptoms. This relationship was especially strong in the entertainment training group, where participants who most improved their self-perception also experienced the greatest mental health benefits.

Interestingly, while both training programs improved self-reported cognition and metacognitive bias, only the targeted training group showed small, non-significant trends toward better objective cognitive performance. This suggests that the subjective feeling of improved cognitive ability—rather than actual test performance—may play a more important role in symptom improvement for people with depression and PTSD.

The researchers believe the performance feedback embedded in both training programs may be key to these improvements. In both training conditions, participants received feedback on their progress and were rewarded for correct performance, helping them to form more accurate beliefs about their cognitive abilities. This positive reinforcement may have helped counteract the negative thinking patterns common in depression and PTSD.

Three months after training ended, participants continued to report lower depression symptoms, and those in the entertainment group also maintained improvements in PTSD symptoms and metacognitive bias. These lasting effects suggest that cognitive training—especially when designed to be engaging and motivating—may have durable benefits for people struggling with self-doubt and negative thinking.

While the study offers promising evidence, the authors note several limitations. The sample consisted primarily of military veterans with a history of mild traumatic brain injury, which may limit the generalizability of the findings to other groups. Additionally, the study did not include a no-treatment control group, making it difficult to rule out the influence of nonspecific effects such as time, attention, or participant expectations.

Future studies with larger, more diverse samples and more rigorous control conditions will be needed to confirm whether improvements in metacognitive bias can directly lead to reductions in depression and PTSD symptoms.

The study, “Negative Global Metacognitive Biases Are Associated With Depressive and Posttraumatic Stress Disorder Symptoms and Improve With Targeted or Game-Based Cognitive Training,” was authored by Sam Agnoli, Henry Mahncke, Sarah-Jane Grant, Zachary T. Goodman, William P. Milberg, Michael Esterman, and Joseph DeGutis.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Optimistic individuals are more likely to respond to SSRI antidepressants
Depression

Optimistic individuals are more likely to respond to SSRI antidepressants

May 19, 2025

People with depression who were more optimistic at the start of treatment—and whose optimism increased during treatment—were more likely to benefit from SSRIs, according to a recent study, raising the possibility of tailoring treatments based on psychological traits.

Read moreDetails
Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression
Ayahuasca

Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression

May 17, 2025

Vaporized DMT produced fast and lasting improvements in depression symptoms and suicidal ideation, according to a new phase 2a trial, highlighting its potential as a scalable, non-invasive alternative to conventional and long-acting psychedelic treatments for severe depression.

Read moreDetails
New research points to gut serotonin as a potential way to treat depression and anxiety
Depression

New research points to gut serotonin as a potential way to treat depression and anxiety

May 16, 2025

New research reveals that serotonin in the gut lining can reduce anxiety and depression symptoms in mice—without the side effects of traditional antidepressants—and may offer a safer alternative for treating mood disorders during pregnancy.

Read moreDetails
New research links postnatal depression to a disrupted oxytocin response during breastfeeding
Depression

New research links postnatal depression to a disrupted oxytocin response during breastfeeding

May 15, 2025

A new study finds that postnatal depression may impair the body’s hormonal response to breastfeeding. While oxytocin nasal spray boosted breast milk levels in healthy mothers, the same effect was not seen in those experiencing depressive symptoms after childbirth.

Read moreDetails
Stress-induced “fixated” eating patterns linked to dopamine disruption, study finds
Depression

New research links antidepressant effects of escitalopram to endocannabinoid system changes

May 12, 2025

In a rodent model of childhood adversity, escitalopram treatment during adolescence reduced signs of emotional distress. The study also found gene-level changes in the endocannabinoid system, pointing to a possible biological mechanism for the drug’s effectiveness.

Read moreDetails
Antidepressants may diminish psilocybin’s effects even after discontinuation
Depression

A single dose of psilocybin might help reduce symptoms in treatment-resistant depression

May 12, 2025

A new open-label study suggests that a single dose of psilocybin, combined with psychological support, may reduce symptoms in people with severe treatment-resistant depression. Improvements were sustained for up to 12 weeks, although effects were weaker in those with PTSD.

Read moreDetails
A pill bottle with pills inside
Depression

Common antidepressant may increase pain sensitivity later in life if taken during adolescence

May 11, 2025

A new animal study shows that adolescent use of fluoxetine, a commonly prescribed antidepressant, may have long-lasting effects on how the brain processes pain. Female mice exposed to the drug displayed increased sensitivity to heat stimuli as adults.

Read moreDetails
Microdoses of LSD enhance neural complexity, study finds
Depression

Little-known psychedelic drug shows promise in treating low motivation in depression

May 9, 2025

Researchers investigating the psychedelic drug DOPR discovered that very low doses can enhance motivation in low-performing mice—without triggering behaviors linked to hallucinations. The findings point to the therapeutic potential of psychedelics at doses too low to alter perception.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Cognitive training may reduce negative self-perceptions in people with depression and PTSD

Genetic essentialism more common among supporters of radical right-wing parties

Enjoying nature, not just visiting it, linked to greater happiness and life satisfaction, study finds

New study finds that nostalgic memories become more bittersweet over time

Narcissists are more likely to become addicted to social networking sites

New study highlights power—not morality—as key motivator behind competitive victimhood

Attractiveness shapes beliefs about whether faces are real or AI-generated, study finds

Neuroforecasting: New research shows brain activity can predict crowd preferences

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy